The Australian drug harms ranking study
Open accessThe DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
Background/Aim: The aim of the current study was to review drug harms as they occur in Australia using the Multi-criteria Decision Analysis (MCDA) methodology adopted in earlier studies in other jurisdictions. Method: A facilitated workshop with 25 experts from across Australia, was held to score 22 drugs on 16 criteria: 9 related to harms that a drug produces in the individual and 7 to harms to others. Participants were guided by facilitators through the methodology and principles of MCDA. In open discussion, each drug was scored on each criterion. The criteria were then weighted using a process of swing weighting. Scoring was captured in MCDA software tool. Results: MCDA modelling showed the most harmful substances to users were fentanyls (part score 50), heroin (part score 45) and crystal methamphetamine (part score 42). The most harmful substances to others were alcohol (part score 41), crystal methamphetamine (part score 24) and cigarettes/tobacco (part score 14). Overall, alcohol was the most harmful drug when harm to users and harm to others was combined. A supplementary analysis took into consideration the prevalence of each substance in Australia. Alcohol was again ranked the most harmful substance overall, followed by cigarettes, crystal methamphetamine, cannabis, heroin and pharmaceutical opioids. Conclusions: The results of this study make an important contribution to the emerging international picture of drug harms. They highlight the persistent and pervasive harms caused by alcohol. Policy implications and recommendations are discussed. Policies to reduce harm from alcohol and methamphetamine should be a priority.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Griswold, M. G., Fullman, N., Hawley, C., Arian, N., Zimsen, S. R. M., Tymeson, H. D., Venkateswaran, V., Tapp, A. D., Forouzanfar, M. H., Salama, J. S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31310-2 · Cited by 3,524
Drug harms in the UK: a multicriteria decision analysis
Nutt, D. J., King, L. A., & Phillips, L. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61462-6 · Cited by 1,681
Self-citationAnthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Bank, W. (1993) · doi:10.1596/978-0-1952-0890-0 · Cited by 1,048
Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61530-5 · Cited by 852
Thokala, P., Devlin, N., Marsh, K., Baltussen, R., Boysen, M., Kalo, Z., Longrenn, T., Mussen, F., Peacock, S., Watkins, J., et al. (2016) · Value in Health · doi:10.1016/j.jval.2015.12.003 · Cited by 739
(EFSA), E. F. S. A. (2005) · EFSA Journal · doi:10.2903/j.efsa.2005.282 · Cited by 582
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
Nutt, D. J., Phillips, L. D., Balfour, D., Curran, H. V., Dockrell, M., Foulds, J., Fagerstrom, K., Letlape, K., Milton, A., Polosa, R., et al. (2014) · European Addiction Research · doi:10.1159/000360220 · Cited by 441
Self-citationCollins, D. J., & Lapsley, H. M. (2008) · PsycEXTRA Dataset · doi:10.1037/e674312010-001 · Cited by 425
Surveying the range and magnitude of alcohol's harm to others in Australia
Laslett, A., Room, R., Ferris, J., Wilkinson, C., Livingston, M., & Mugavin, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03445.x · Cited by 245
Research works printed but not linked: 8
- Claydon C, 2017, National Drug Strategy Household Survey 2016: Detailed Findings
- European Monitoring Centre for Drugs and Drug Addiction, 2018, European Drug Report 2018: Trends and Developments
- O’Brien J, 2017, National Wastewater Drug Monitoring Program-Report 1
- United Nations Framework for Climate Change, 2002, FCCC/SBI/2002/INF, 14
- United Nations Office on Drugs and Crime (1972) https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1973-01-01_4_page008.html (accessed 3 April 2019).
- 10.1596/0-1952-0890-0 · DOI · Paper page
- World Drug Report, 2018, XI, 9
- World Health Organization, 2015, Global Status Report on Alcohol and Health 2014
Cited by
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
Self-citationSolmi, M., De Toffol, M., Kim, J. Y., Choi, M. J., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 271
Self-citationManning, V., Garfield, J. B. B., Staiger, P. K., Lubman, D. I., Lum, J. A. G., Reynolds, J., Hall, K., Bonomo, Y. A., Lloyd‐Jones, M., Wiers, R. W. H. J., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3446 · Cited by 118
Self-citationPsychedelic perceptions: mental health service user attitudes to psilocybin therapy
Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O’Keane, V., et al. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02668-2 · Cited by 84
Liu, J., Liu, L., Tu, Y., Li, S., & Li, Z. (2021) · Information Processing & Management · doi:10.1016/j.ipm.2021.102796 · Cited by 78
Metadata
- Authors
- Bonomo, Y., Norman, A., Biondo, S., Bruno, R., Daglish, M., Dawe, S., Egerton-Warburton, D., Karro, J., Kim, C., Lenton, S., Lubman, D. I., Pastor, A., Rundle, J., Ryan, J., Gordon, P., Sharry, P., Nutt, D., & Castle, D.
- Affiliations
- The University of Melbourne (AU)
- Victorian Alcohol and Drug Association (VAADA), Melbourne, VIC, Australia
- University of Tasmania (AU)
- The University of Queensland (AU)
- Griffith University (AU)
- Department of Medicine, School of Clinical Sciences at Monash Health, Melbourne, VIC, Australia
- St Vincent's Hospital Melbourne (AU)
- The Royal Melbourne Hospital (AU)
- Curtin University (AU)
- Eastern Health (AU)
- Western Australian Network of Alcohol and Drug Agencies, Perth, WA, Australia
- Penington Institute, Melbourne, VIC, Australia
- Catalyze APAC, Sydney, NSW, Australia
- UNSW Sydney (AU)
- Imperial College London (GB)
- Corresponding author
- Bonomo, Yvonne
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-05-13
- Volume
- 33
- Issue
- 7
- Pages
- 759-768
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2945519735
- Cited by
- 154
- References
- 32
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 24 · 2023: 25 · 2022: 34 · 2021: 23 · 2020: 14 · 2019: 3
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-10-01)
- Open access
- green
- figshare.com
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- UTAS Research Repository (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Griffith Research Online (submittedVersion)
- Funders
- Inclusive Health Fund (None)
- St Vincent’s Health Australia
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- multi-criteria decision making, harm to others, alcohol harm, methamphetamine, heroin, fentanyl, tobacco, cannabis, prescription opioids, harm reduction policy, Australia
- MeSH terms
- Cigarette Smoking, Alcohol Drinking, Australia, Decision Support Techniques, Humans, Public Policy, Illicit Drugs, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Australian drug harms ranking study. https://app.cochat.ai/papers/10.1177/0269881119841569
- The paper
- Bonomo, Y., Norman, A., Biondo, S., Bruno, R., Daglish, M., Dawe, S., Egerton-Warburton, D., Karro, J., Kim, C., Lenton, S., Lubman, D. I., Pastor, A., Rundle, J., Ryan, J., Gordon, P., Sharry, P., Nutt, D., & Castle, D. (2019). The Australian drug harms ranking study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881119841569
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.